Oliver Howes
Oliver Howes
Dept of Psychiatry, King's College, UK
Geen geverifieerd e-mailadres
Geciteerd door
Geciteerd door
The dopamine hypothesis of schizophrenia: version III—the final common pathway
OD Howes, S Kapur
Schizophrenia bulletin 35 (3), 549-562, 2009
The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies
OD Howes, J Kambeitz, E Kim, D Stahl, M Slifstein, A Abi-Dargham, ...
Archives of general psychiatry 69 (8), 776-786, 2012
Elevated striatal dopamine function linked to prodromal signs of schizophrenia
OD Howes, AJ Montgomery, MC Asselin, RM Murray, I Valli, P Tabraham, ...
Archives of general psychiatry 66 (1), 13-20, 2009
Cognitive functioning in prodromal psychosis: a meta-analysis
P Fusar-Poli, G Deste, R Smieskova, S Barlati, AR Yung, O Howes, ...
Archives of general psychiatry 69 (6), 562-571, 2012
Schizophrenia: an integrated sociodevelopmental-cognitive model
OD Howes, RM Murray
The Lancet 383 (9929), 1677-1687, 2014
Glutamate and dopamine in schizophrenia: An update for the 21st century
O Howes, R McCutcheon, J Stone
Journal of psychopharmacology 29 (2), 97-115, 2015
Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology
GM Goodwin, PM Haddad, IN Ferrier, JK Aronson, TRH Barnes, ...
Journal of Psychopharmacology 30 (6), 495-553, 2016
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
The role of genes, stress, and dopamine in the development of schizophrenia
OD Howes, R McCutcheon, MJ Owen, RM Murray
Biological psychiatry 81 (1), 9-20, 2017
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study
OD Howes, SK Bose, F Turkheimer, I Valli, A Egerton, LR Valmaggia, ...
American Journal of Psychiatry 168 (12), 1311-1317, 2011
Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study
PS Bloomfield, S Selvaraj, M Veronese, G Rizzo, A Bertoldo, DR Owen, ...
American Journal of Psychiatry 173 (1), 44-52, 2016
Dopamine synthesis capacity in patients with treatment-resistant schizophrenia
A Demjaha, RM Murray, PK McGuire, S Kapur, OD Howes
American Journal of Psychiatry 169 (11), 1203-1210, 2012
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
OD Howes, F Vergunst, S Gee, P McGuire, S Kapur, D Taylor
The British Journal of Psychiatry 201 (6), 481-485, 2012
Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness
MA Calcia, DR Bonsall, PS Bloomfield, S Selvaraj, T Barichello, ...
Psychopharmacology 233 (9), 1637-1650, 2016
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
AM Meaney, S Smith, OD Howes, M O'Brien, RM Murray, V O'Keane
The British Journal of Psychiatry 184 (6), 503-508, 2004
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study
P Fusar-Poli, OD Howes, P Allen, M Broome, I Valli, MC Asselin, ...
Archives of general psychiatry 67 (7), 683-691, 2010
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
O Howes, S Bose, F Turkheimer, I Valli, A Egerton, D Stahl, L Valmaggia, ...
Molecular psychiatry 16 (9), 885-886, 2011
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging
OD Howes, A Egerton, V Allan, P McGuire, P Stokes, S Kapur
Current pharmaceutical design 15 (22), 2550-2559, 2009
Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis
T Pillinger, K Beck, C Gobjila, JG Donocik, S Jauhar, OD Howes
JAMA psychiatry 74 (3), 261-269, 2017
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function
A Demjaha, A Egerton, RM Murray, S Kapur, OD Howes, JM Stone, ...
Biological psychiatry 75 (5), e11-e13, 2014
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20